Drug repurposing in NCDs: benefits and challenges

dc.contributor.advisorKabir, Eva Rahman
dc.contributor.authorNasir, Naushin Sadia
dc.date.accessioned2021-12-26T09:03:47Z
dc.date.available2021-12-26T09:03:47Z
dc.date.issued2021-04
dc.descriptionCataloged from PDF version of thesis report.
dc.descriptionIncludes bibliographical references (pages 34-49).
dc.descriptionThis thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
dc.description.abstractThis review focuses on repurposing of drugs for the treatment of noncommunicable diseases. Drug repurposing is the development of new indications for existing drugs. Noncommunicable diseases are causing large number of deaths every year. Therefore, drug repurposing is an effective strategy for the treatment of noncommunicable diseases. This review discusses the methods, benefits and challenges of drug repurposing as well as all the approved repurposed drugs for NCDs and the repurposed drugs that are awaiting approval by the FDA. Considering the challenges faced due to repurposing of drugs, some recommendations are put forward to improve the future of drug repurposing.
dc.identifier.otherID 17146047
dc.identifier.otherhttps://dspace.bracu.ac.bd/server/api/core/items/174a2983-5045-40fe-a66d-d77c99d16039
dc.identifier.urihttp://hdl.handle.net/10361/15764
dc.language.isoen
dc.publisherBRAC University
dc.sourceBRAC University Institutional Repository
dc.subjectDrug repurposing
dc.subjectNoncommunicable disease
dc.subjectMarket and data exclusivity
dc.subjectBenefits and challenges
dc.titleDrug repurposing in NCDs: benefits and challenges
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
17146047_PHR.pdf
Size:
1.16 MB
Format:
Adobe Portable Document Format